Kalos Management’s Cytosorbents Corp CTSO Stock Holding History

Kalos Management’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,150	Closed	-$97K	–	253
2020 Q3	$97K	Sell	12,150 -1,350	-10%	-$12.2K	0.04%	218
2020 Q2	$133K	Hold	13,500	–	–	0.06%	199
2020 Q1	$104K	Hold	13,500	–	–	0.05%	188
2019 Q4	$52K	Hold	13,500	–	–	0.02%	198
2019 Q3	$67K	Hold	13,500	–	–	0.03%	190
2019 Q2	$89K	Sell	13,500 -608	-4%	-$4.18K	0.04%	184
2019 Q1	$106K	Sell	14,108 -592	-4%	-$4.61K	0.07%	150
2018 Q4	$120K	Hold	14,700	–	–	0.06%	177
2018 Q3	$176K	Sell	14,700 -2,950	-17%	-$37K	0.09%	144
2018 Q2	$125K	Hold	17,650	–	–	0.06%	189
2018 Q1	$125K	Buy	17,650 +7,100	+67%	+$53.7K	0.07%	113
2017 Q4	$73K	Buy	+10,550	New	+$67.1K	0.03%	208

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kalos Management's CTSO Position: Q4 2020 in Review

Kalos Management sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 12,150 shares — an estimated $97K sold.

Kalos Management first reported a position in CTSO in Q4 2017 and held it in 12 quarters. The position peaked at $176K in Q3 2018. 94 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

Kalos Management reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
Kalos Management sold 12,150 Cytosorbents Corp shares in Q4 2020, an estimated $97K.
Kalos Management first reported a position in Cytosorbents Corp in Q4 2017 and held it in 12 quarters.
Kalos Management's Cytosorbents Corp position peaked at $176K in Q3 2018.
94 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Kalos Management's 13F filing for Q4 2020, filed 11 Feb 2021.